Bluejay Diagnostics (BJDX) Return on Capital Employed (2021 - 2026)
Bluejay Diagnostics (BJDX) posted Return on Capital Employed of 141.62% for Q1 2026, little changed sequentially from 142.32% in Q4 2025, and up 94.0% YoY from 73.0% in Q1 2025.
Bluejay Diagnostics (BJDX) Return on Capital Employed (2021 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Return on Capital Employed for 6 years, with the latest figure at 141.62% in Q1 2026.
- Quarterly Return on Capital Employed rose 94.0% year-over-year to 141.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 141.62% (up 94.0% YoY) and the FY2025 annual result came in at 120.52%, up 2424.0% from the prior year.
- Return on Capital Employed held at 141.62% in Q1 2026 per BJDX's latest filing, from 142.32% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 26.33% in Q1 2022 and troughed at 291.92% in Q1 2024.
- A 5-year average of 128.64% and a median of 140.02% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed sank 19985 bps in 2024, then surged 14936 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 71.82% in 2022, then tumbled by 200 bps to 215.44% in 2023, then soared by 50 bps to 107.09% in 2024, then tumbled by 33 bps to 142.32% in 2025, then increased by 0 bps to 141.62% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 141.62%, 142.32%, and 155.09% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.08% |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - | -114.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -114.22% |
| Mar 31, 2026 | -141.62% |
| Dec 31, 2025 | -142.32% |
| Sep 30, 2025 | -155.09% |
| Jun 30, 2025 | -140.02% |
| Mar 31, 2025 | -142.56% |
| Dec 31, 2024 | -107.09% |
| Sep 30, 2024 | -93.79% |
| Jun 30, 2024 | -153.15% |
| Mar 31, 2024 | -291.92% |
| Dec 31, 2023 | -215.44% |
| Sep 30, 2023 | -186.58% |
| Jun 30, 2023 | -138.16% |
| Mar 31, 2023 | -92.07% |
| Dec 31, 2022 | -71.82% |
| Sep 30, 2022 | -53.61% |
| Jun 30, 2022 | -35.29% |
| Mar 31, 2022 | -26.33% |
| Dec 31, 2021 | -27.65% |